Principal Financial Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $337K | Sell |
|
|||||
|
2025
Q2 | $230K | Sell |
|
|||||
|
2025
Q1 | $268K | Sell |
|
|||||
|
2024
Q4 | $275K | Sell |
|
|||||
|
2024
Q3 | $461K | Sell |
|
|||||
|
2024
Q2 | $675K | Sell |
|
|||||
|
2024
Q1 | $450K | Sell |
|
|||||
|
2023
Q4 | $176K | Sell |
|
|||||
|
2023
Q3 | $134K | Buy |
|
|||||
|
2023
Q2 | $194K | Buy |
|
|||||
|
2023
Q1 | $238K | Buy |
|
|||||
|
2022
Q4 | $267K | Buy |
|
|||||
|
2022
Q3 | $175K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.15M | Sell |
|
|||||
|
2021
Q2 | $1.19M | Buy |
|
|||||
|
2021
Q1 | $513K | Buy |
|
|||||
|
2020
Q4 | $556K | Buy |
|